Abstract

CLINICAL MANAGEMENT OF CLIMACTERIC STATE IN FEMALE BY AMRITADI RASAYANA

*Dr.B.Vijayalakshmi

Abstract

The world population of the elderly is increasing, and by the year 2050 adults above 65 yrs. will comprise 1/5th of the global population. Steadily increased life expectancy leads to increase in percentage of women in the post menopausal age. Menopause is a natural physiological process, which cannot be escaped by any women in her course of life. It occurs at the age of 40-55 yrs. It is the ending of a woman’s monthly menstrual periods and ovulation. It also signals other changes to the body and mind. The aim includes improving the quality of life in perimenopausal women by alleviating symptoms. In modern science for prevention and management of perimenopausal symdrome, HRT-(Hormone Replacement Therapy) is to be given not for months even for years. Recent research findings suggest that longterm HRT use is associated with more risks than benefits. There is an early harm of coronary artery disease, stroke, thrombo-embolism and prone to cancer of uterus and breast etc. Such a situation forces the research in our system of medicine to evolve a comprehensive clinical trial with the preparation of the compound drug ‘Amritadi Rasayana’. The trial was conducted on 30 patients taken from outpatient department of prasootitantra & streeroga, P.G unit, Dr.B.R.K.R.Govt.AyurvedicHospital, Erragadda, Hyderbad. Though the perimenopausal syndrome is not a disease, it requires support and management till the women feels comfort. . The diagnosis was made clinically. Subjective symptoms are taken up as the parameters for assessment. Results were graded. The patients were observed and classified into different categories for the purpose of statistical analysis. The gross results were calculated as 83% being completely relief, 10% partially relief, while 7% not responded to the treatment.

Keywords: